|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Jun 15, 2022 |
Title |
L34 |
Sample type |
SRA |
|
|
Source name |
Acute Myeloid Leukemia_Plasma
|
Organism |
Homo sapiens |
Characteristics |
diagnosis: Acute Myeloid Leukemia training/validation group in diagnostic model: Training training/validation group in survival analysis: NA age: 75.87 gender: male vital status (0: censored; 1: event): NA survival (months): NA
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Plasma was separated from whole blood by centrifuge 1350 g for 10 minutes at 4 °C. Plasma cfDNA was extracted using QIAamp Circulating Nucleic Acid Kit (QIAGEN, Germantown, MD) following manufacturer’s instructions. Briefly, cfDNA was ligated with barcode adaptors after end repair and A-tailing. Then cfDNA was purified and was incubated with 50 mM HEPES buffer (pH 8.0), 25 mM MgCl2, 100 μM N3-UDP-azide-glucose and 1 μM T4 Phage β-gulcosyltransferase at 37 °C for 1 hour. After purification, cfDNA was incubated with 1 μL DBCO-PEG4-DBCO (a click chemistry tool, 4.5 mM stock in DMSO) at 37 °C for 2 hours. Next, the cfDNA was purified and incubated with 5 μL pre-washed C1 Streptavidin beads (Thermo Fisher Scientific, Waltham, MA) for 15 min. The beads were subsequently washed for 5 minutes eight times. The captured DNA fragments were amplified with 15-18 cycles of PCR. The PCR products were purified with AMPure XP beads according to the manufacturer’s instructions. The concentration of DNA library was measured using a Qubit Fluorometer with dsDNA HS Assay Kit (Thermo Fisher Scientific, Waltham, MA) and Bioanalyzer 2100 with Agilent High Sensitivity Kit (Agilent Technologies, Santa Clara, CA).
|
|
|
Library strategy |
OTHER |
Library source |
genomic |
Library selection |
other |
Instrument model |
NextSeq 550 |
|
|
Data processing |
Basecalls were converted using bcl2fastq2. Sequencing quality of raw reads were evaluated using FastQC, and trimmed adaptors and low quality reads (Phred quality score < 15) using Trimmomatic High quality reads were mapped to hg19 genome using bowtie2 with end-to-end mode Duplicate reads were removed using samtools. The reads were counted for overlap with gene bodies (annotated by the GENCODE Project) using featureCounts. Genome_build: hg19 Supplementary_files_format_and_content: txt file for all sample with raw reads count summarised to genebody region.
|
|
|
Submission date |
Dec 24, 2020 |
Last update date |
Jun 15, 2022 |
Contact name |
Zejuan Li |
E-mail(s) |
[email protected]
|
Phone |
3462385129
|
Organization name |
Houston Methodist Hospital
|
Department |
Department of Pathology and Genomic Medicine
|
Street address |
6565 Fannin St, MC227
|
City |
Houston |
State/province |
Texas |
ZIP/Postal code |
77030 |
Country |
USA |
|
|
Platform ID |
GPL21697 |
Series (1) |
GSE163846 |
Cell free DNA 5-hydroxymethylcytosine as an emerging marker of acute myeloid leukemia |
|
Relations |
BioSample |
SAMN17152800 |
SRA |
SRX9733008 |
Supplementary data files not provided |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|